Gyre Therapeutics Inc. (GYRE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Gyre Therapeutics Inc.

    NASDAQ: GYRE · Real-Time Price · USD
    7.16
    -0.13 (-1.78%)
    At close: Sep 26, 2025, 3:59 PM
    7.50
    4.75%
    After-hours: Sep 26, 2025, 05:47 PM EDT

    Gyre Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 17.9M -85.48M 2.3M -87.93M
    Depreciation & Amortization
    		 1.59M 1.11M 1.13M 290K
    Stock-Based Compensation
    		 831K 7.28M 13.37M 3.4M
    Other Working Capital
    		 -4.02M 4.22M 1.11M -5.39M
    Other Non-Cash Items
    		 -7.27M 96.68M -337K 3.89M
    Deferred Income Tax
    		 -1M -1.16M -838K -3.89M
    Change in Working Capital
    		 -15.69M 7.46M -4.95M 483K
    Operating Cash Flow
    		 -3.64M 25.89M 10.68M -83.75M
    Capital Expenditures
    		 -2.31M -8.59M -5M -839K
    Cash Acquisitions
    		 n/a 4.02M 55.5M n/a
    Purchase of Investments
    		 -15.47M -15.73M -50.51M n/a
    Sales Maturities Of Investments
    		 n/a n/a 57.5M 49.03M
    Other Investing Acitivies
    		 -2.1M 471K -2.06M n/a
    Investing Cash Flow
    		 -19.88M -19.76M 55.43M 48.19M
    Debt Repayment
    		 n/a n/a -466.28K -6.7M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a -45.03M n/a
    Other Financial Acitivies
    		 1.33M n/a 486.28K 6.7M
    Financial Cash Flow
    		 2.1M 2.5M -45.01M 49.55M
    Net Cash Flow
    		 -21.7M 8.33M 25.18M 13.99M
    Free Cash Flow
    		 -5.96M 17.31M -38.09M -84.59M

    Add to Watchlist